Suggestions
Jacob Lissoos
Search & Evaluate, Corporate Development, Eli Lilly Genetic Medicine
Professional Background
Jacob Lissoos is a dynamic and accomplished professional with a unique blend of scientific expertise and business acumen. Starting his journey as a wet lab scientist, Jacob has adeptly transitioned into the realms of corporate development and innovation scouting, focusing primarily on early-stage genomic medicine and nanomedicine platforms. His diverse experience equips him with a well-rounded understanding of the complexities inherent in drug development, especially at the intersection of science, intellectual property, and business strategy.
In his current role as a Manager of Search and Evaluate for Genetic Medicine at Eli Lilly and Company, Jacob plays a crucial part in identifying promising technologies and partnerships that will drive the development of pioneering therapies. His insight into innovative drug platforms positions him as a valuable resource in the pursuit of medical advancements that can profoundly impact patient outcomes.
Education and Achievements
Jacob has a solid educational foundation that supports his professional endeavors. He earned his Master of Business Administration (MBA) with a concentration in Finance from the prestigious Questrom School of Business at Boston University. This advanced education has provided Jacob with critical financial insights and managerial skills vital for navigating the corporate landscape of life sciences.
Prior to his MBA, Jacob completed his Bachelor of Science (BS) in Chemical and Biological Engineering at Tufts University. His academic journey continued at Harvard Extension School, where he studied Pharmacology-Essentials, broadening his understanding of drug action and development processes. This multifaceted education not only showcases Jacob's dedication to academic excellence but also enriches his capability to contribute meaningfully to the field of genomic medicine.
With a deep commitment to the field of intellectual property, Jacob holds a USPTO Patent Agent license. This credential enables him to provide innovative solutions and guidance in protecting the intellectual advancements that stem from scientific innovation, particularly significant in a rapidly evolving industry like biotechnology.
Notable Experiences
Jacob's professional path has included numerous significant roles that have honed his skills and expertise. At Eli Lilly and Company, where he served as both a Senior Associate and now as a Manager, Jacob’s focus has been on evaluating cutting-edge genetic medicine technologies. His work drives collaborations that aim to bring novel therapies to patients who require them most.
Before joining Eli Lilly, Jacob played an essential role at the University of Chicago as an Associate in Technology Transfer, where he facilitated the movement of groundbreaking scientific discoveries from academic laboratories to real-world applications. His tenure as a Research Associate at Adimab, LLC, significantly contributed to his understanding of the intricacies of antibody discovery and development.
Jacob also has valuable experience as a CRTA Summer Fellow at the National Cancer Institute (NCI), where he engaged in advanced research focused on cancer biology. Furthermore, his foundational research experience includes being a Research Associate in the Van Deventer Lab at Tufts University and participating as a NUTORC Summer Fellow at Northwestern University’s Feinberg School of Medicine. These formative experiences enriched his laboratory skills and provided him with a robust framework for understanding scientific research and its translational applications.
Personal Impact and Philosophy
Jacob is deeply passionate about fostering innovation that leads to the development of novel therapies, particularly in the fields of genomic medicine and nanomedicine. He believes in harnessing collaboration and leveraging intellectual property as tools to bridge the gap between scientific discovery and market-ready solutions. Jacob's proactive approach to building meaningful drug development collaborations reflects his commitment to improving patient lives. His strong belief in the transformative power of science inspires his work and drives his career forward.
Outside of his professional scope, Jacob consistently seeks to stay at the forefront of emerging trends within the biotechnology sector, ensuring that his knowledge and skills remain relevant in a fast-paced environment. He maintains that continuous learning and adaptability are keys to success in the life sciences field. Jacob is also devoted to sharing knowledge and mentoring aspiring professionals, fostering a culture of innovation and growth in the biotechnology community.
In summary, Jacob Lissoos embodies a rare blend of scientific rigor, business insight, and a passion for patient-centered innovations. His journey reflects a commitment to excellence in both science and business, positioning him as a leader in the dynamic world of genomic medicine and drug development.